Steenwyk sqcr

Associate Professor

Division: Cardiothoracic Anesthesiology

Contact Information: or 205-934-7424

Clinical Interests: pediatric cardiac anesthesia, adult cardiac anesthesia, general anesthesia, simulation, quality improvement initiatives, clinical research

Education and Degrees
UAB School of Medicine, Anesthesiology Residency, 2003
Baptist Health Systems, Internship, 2000
UAB School of Medicine, M.D., 1999
Belhaven College, B.S. (Biology), 1994

Professional Societies
Society of Pediatric Anesthesia
Society of Cardiovascular Anesthesiologists          
Alabama State Society of Anesthesiologists

Selected publications

For the most recent list of publications, please see PubMed.

Nielsen VG, Steenwyk BL, Gurley WQ, Pereira SJ, Lell WA, Kirklin JK.  Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro. J Heart Lung Transplant. 2006 Jun;25(6):653-63

Nielsen VG, Steenwyk BL, Gurley WQ. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII. J Heart Lung Transplant. 2006 Oct;25(10):1247-52

Nielsen VG, Audu P, Cankovic L, Lyerly RT 3rd, Steenwyk BL, Armstead V, Powell G. Qualitative thrombelastographic detection of tissue factor in human plasma. Anesth Analg. 2007 Jan;104(1):59-64

Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis. 2007 Jan;18(1):35-9

Steenwyk BL, Kirklin JK, Gurley WQ, Nielsen VG. The hemostatic history of a 15-month-old child implanted with a Berlin heart left ventricular assist device. Anesth Analg. 2007 Mar;104(3):538-40